269 related articles for article (PubMed ID: 20006793)
1. Disorders of lipid metabolism and chronic kidney disease in the elderly.
Choudhury D; Tuncel M; Levi M
Semin Nephrol; 2009 Nov; 29(6):610-20. PubMed ID: 20006793
[TBL] [Abstract][Full Text] [Related]
2. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
[TBL] [Abstract][Full Text] [Related]
3. Statins and lipid-lowering strategies in cardiorenal patients.
Bianchi S; Grimaldi D; Bigazzi R
Contrib Nephrol; 2011; 171():143-150. PubMed ID: 21625103
[TBL] [Abstract][Full Text] [Related]
4. Statins for treatment of dyslipidemia in chronic kidney disease.
Shurraw S; Tonelli M
Perit Dial Int; 2006; 26(5):523-39. PubMed ID: 16973506
[TBL] [Abstract][Full Text] [Related]
5. Effects of atorvastatin on renal function in patients with dyslipidemia and chronic kidney disease: assessment of clinical usefulness in CKD patients with atorvastatin (ASUCA) trial.
Kimura G; Kasahara M; Ueshima K; Tanaka S; Yasuno S; Fujimoto A; Sato T; Imamoto M; Kosugi S; Nakao K
Clin Exp Nephrol; 2017 Jun; 21(3):417-424. PubMed ID: 27392909
[TBL] [Abstract][Full Text] [Related]
6. Dyslipidemia in patients with chronic kidney disease.
Hager MR; Narla AD; Tannock LR
Rev Endocr Metab Disord; 2017 Mar; 18(1):29-40. PubMed ID: 28000009
[TBL] [Abstract][Full Text] [Related]
7. [Statins in patients with kidney failure: efficacy, tolerance, and prescription guidelines in patients with chronic kidney disease and renal transplant].
Karie S; Launay-Vacher V; Deray G; Isnard-Bagnis C
Presse Med; 2006 Feb; 35(2 Pt 1):219-29. PubMed ID: 16493350
[TBL] [Abstract][Full Text] [Related]
8. Etiology and management of dyslipidemia in children with chronic kidney disease and end-stage renal disease.
Khurana M; Silverstein DM
Pediatr Nephrol; 2015 Dec; 30(12):2073-84. PubMed ID: 25801207
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of dyslipidemia in chronic kidney disease.
Iseki K
Clin Exp Nephrol; 2014 Apr; 18(2):185-8. PubMed ID: 24408220
[TBL] [Abstract][Full Text] [Related]
10. Statins in the management of dyslipidemia associated with chronic kidney disease.
Epstein M; Vaziri ND
Nat Rev Nephrol; 2012 Feb; 8(4):214-23. PubMed ID: 22349484
[TBL] [Abstract][Full Text] [Related]
11. [Statins and kidney disease].
Bigazzi R; Grimaldi D; Bianchi S
G Ital Nefrol; 2012; 29(2):160-73. PubMed ID: 22538946
[TBL] [Abstract][Full Text] [Related]
12. Statins and diabetes.
Carmena R; Betteridge DJ
Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Hyperlipidemia Changes With Level of Kidney Function-Rationale.
Ananthakrishnan S; Kaysen GA
Adv Chronic Kidney Dis; 2016 Jul; 23(4):247-54. PubMed ID: 27324678
[TBL] [Abstract][Full Text] [Related]
14. Lipid changes and statins in chronic renal insufficiency and dialysis.
Wanner C; Krane V; Metzger T; Quaschning T
J Nephrol; 2001; 14 Suppl 4():S76-80. PubMed ID: 11798151
[TBL] [Abstract][Full Text] [Related]
15. [Statins: what is their place in the treatment of chronic kidney insufficiency?].
Ponte B; Bourquin V; Stoermann-Chopard C
Rev Med Suisse; 2009 Feb; 5(192):463-4, 466-8. PubMed ID: 19317313
[TBL] [Abstract][Full Text] [Related]
16. Managing dyslipidemia in chronic kidney disease.
Weiner DE; Sarnak MJ
J Gen Intern Med; 2004 Oct; 19(10):1045-52. PubMed ID: 15482558
[TBL] [Abstract][Full Text] [Related]
17. Lowering cholesterol in chronic kidney disease: is it safe and effective?
Wong MG; Wanner C; Knight J; Perkovic V
Eur Heart J; 2015 Nov; 36(43):2988-95. PubMed ID: 26289904
[TBL] [Abstract][Full Text] [Related]
18. Controversies Regarding Lipid Management and Statin Use for Cardiovascular Risk Reduction in Patients With CKD.
Markossian T; Burge N; Ling B; Schneider J; Pacold I; Bansal V; Leehey D; Stroupe K; Chang A; Kramer H
Am J Kidney Dis; 2016 Jun; 67(6):965-77. PubMed ID: 26943983
[TBL] [Abstract][Full Text] [Related]
19. Lipid Management in Chronic Kidney Disease: Systematic Review of PCSK9 Targeting.
Zheng-Lin B; Ortiz A
Drugs; 2018 Feb; 78(2):215-229. PubMed ID: 29299849
[TBL] [Abstract][Full Text] [Related]
20. Statin treatment for dyslipidemia in chronic kidney disease and renal transplantation: a review of the evidence.
Kanbay M; Turgut F; Covic A; Goldsmith D
J Nephrol; 2009; 22(5):598-609. PubMed ID: 19809992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
